Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents.
Animals
Atherosclerosis
/ drug therapy
Biomarkers
Blood Coagulation
Blood Coagulation Factors
/ metabolism
Blood Platelets
/ metabolism
Disease Management
Disease Susceptibility
Humans
Inflammation
/ drug therapy
Inflammation Mediators
/ metabolism
Platelet Activation
Platelet Aggregation Inhibitors
/ pharmacology
ADP
Antiplatelet therapy
Atherosclerosis
Inflammation
Platelet-activating factor
Thrombin
Thromboxane
Journal
Blood reviews
ISSN: 1532-1681
Titre abrégé: Blood Rev
Pays: England
ID NLM: 8708558
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
06
05
2019
revised:
22
03
2020
accepted:
07
04
2020
pubmed:
29
4
2020
medline:
4
9
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
Platelets are central to inflammation-related manifestations of cardiovascular diseases (CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A
Identifiants
pubmed: 32340775
pii: S0268-960X(20)30044-8
doi: 10.1016/j.blre.2020.100694
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Coagulation Factors
0
Inflammation Mediators
0
Platelet Aggregation Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100694Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.